Nigella sativa oil

DB28165InvestigationalOrganism Based Therapies

Nigella Sativa Oil is a biologic drug. Nigella Sativa Oil is under investigation in clinical trial NCT06823544 (A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and...

Mechanism: Pharmacologically active on Polyunsaturated fatty acid 5-lipoxygenase, Acetylcholinesterase, and Human Cyclooxygenases
Curator reviewed
Also known as: Black Seed Oil

Resolves to

Targets

P09917ALOX5P22303ACHE

What you can answer from here — as of July 01, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Nigella sativa oil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account